Mackay Shields LLC has filed its 13F form on October 31, 2024 for Q3 2024 where it was disclosed a total value porftolio of $581 Million distributed in 368 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Nuveen Amt Free Quality Municipal Income Fund with a value of $47.9M, Ishares Gold Trust with a value of $46.2M, Danaher Corp with a value of $41.8M, Nuveen Municipal Credit Income Fund with a value of $40.5M, and Nuveen Amt Free Municipal Credit Income Fund with a value of $33M.
Examining the 13F form we can see an increase of $16.4M in the current position value, from $565M to 581M .
Below you can find more details about Mackay Shields LLC portfolio as well as his latest detailed transactions.
Portfolio value
$581 Million
$395 Million
$77.2 Million
$55.4 Million
$41.8 Million
$11.7 Million
$293,000
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.41%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.33%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 2.16%
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.42%
-
$0
0.0% of portfolio
-
Q2 2024
Added 3.94%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 25.1%
American Airlines Group Inc
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.28%
Amphastar Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.07%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.08%
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.07%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 0.12%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 99.28%
Biomarin Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 0.08%
-
$0
0.0% of portfolio
-
Q1 2023
Added 140.0%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.59%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 2.43%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.34%
Envista Holdings Corporation
-
$0
0.0% of portfolio
-
Q3 2024
New
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
New
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 89.08%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.36%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.43%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.08%
Live Nation Entertainment In
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.35%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.28%
Marriott Vacations Worldwide
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.75%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.29%
Microchip Technology Inc.
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.23%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.35%
Hewlett Packard Enterprise C
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.43%
-
$0
0.0% of portfolio
-
Q2 2024
Added 7.98%
-
$0
0.0% of portfolio
-
Q3 2024
Added 937.85%
-
$0
0.0% of portfolio
-
Q4 2023
Added 3.52%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 2.74%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.05%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.22%
Forum Energy Technologies In
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 49.5%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 0.23%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.78%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 0.4%
Mirum Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2024
Added 7.5%
